{"id":"W4253607854","doi":"10.1182/blood.v116.21.3055.3055","title":"Phase I-II Trial of Oral Cyclophosphamide, Prednisone and Lenalidomide (Revlimid®) (CPR) for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Southlake Regional Health Center; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Internal medicine; Regimen; Thalidomide; Gastroenterology; Cyclophosphamide; Prednisone; Multiple myeloma; Dexamethasone; Bortezomib; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00182025,0.001659436,0.001805661,0.0003953303,0.000393152,0.001013901,0.0009400692,0.001136865,0.003937374],"category_scores_gemma":[0.0007269006,0.0006924123,0.001079317,0.0003594315,0.001063647,0.0006829915,0.000351937,0.003420158,0.001109654],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009315028,"about_ca_system_score_gemma":0.001149047,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001067424,"about_ca_topic_score_gemma":0.00248576,"domain_scores_codex":[0.9996024,0.0002010246,0.00002251844,0.00006091001,0.00003524055,0.00007787835],"domain_scores_gemma":[0.9994867,0.00008048681,0.00008800137,0.00004254393,0.00002668625,0.0002754877],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8346606,0.06265153,0.004219871,0.0006934908,0.001175502,0.0002161631,0.0002441515,0.001605246,0.01638423,0.0003993599,0.005298503,0.07245132],"study_design_scores_gemma":[0.7934789,0.1975427,0.005109444,0.00002560608,0.0002427927,0.0001402919,0.00003624917,0.0007524831,0.0008664416,0.0001348182,0.001653004,0.00001727222],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.988605,0.003020345,0.0003783001,0.0007393219,0.0002929005,0.003219736,0.0008469694,0.00011781,0.002779615],"genre_scores_gemma":[0.9861077,0.002301748,0.001408839,0.001545618,0.0003636251,0.002412899,0.002100658,0.0000226335,0.003736266],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003937374,"threshold_uncertainty_score":0.01317179,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02025790824414703,"score_gpt":0.2920362068685248,"score_spread":0.2717782986243778,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}